ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,474Medicare Part D Prescriptions Filled, Including Refills

Rank: 196 out of 1185

$504K Total Retail Price of All Prescriptions

Rank: 267 out of 1185

353 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,311 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LEVOTHYROXINE SODIUM 508 507 1 3
DONEPEZIL HCL 356 356 2 32
LISINOPRIL 356 356 2 4
CITALOPRAM HBR 323 308 4 22
OMEPRAZOLE 312 294 5 6
SIMVASTATIN 282 282 6 5
FUROSEMIDE 274 274 7 8
MIRTAZAPINE 227 213 8 57
POTASSIUM CHLORIDE 207 207 9 18
NAMENDA 201 201 10 43
AMLODIPINE BESYLATE 194 194 11 1
LOSARTAN POTASSIUM 171 171 12 26
HYDROCODONE-ACETAMINOPHEN 171 171 S3 12 2
GABAPENTIN 170 158 14 13
METOPROLOL SUCCINATE 169 169 15 20
PRAVASTATIN SODIUM 150 150 16 7
METOPROLOL TARTRATE 139 138 17 10
QUETIAPINE FUMARATE 131 131 18 93
DIGOXIN 130 130 19 67
SERTRALINE HCL 130 130 19 25
WARFARIN SODIUM 129 129 21 21
DIVALPROEX SODIUM 124 111 22 96
HYDROCHLOROTHIAZIDE 123 123 23 12
RANITIDINE HCL 117 117 24 17
TAMSULOSIN HCL 117 117 24 34
POLYETHYLENE GLYCOL 3350 107 103 26 60
METFORMIN HCL 106 106 27 9
FAMOTIDINE 86 86 28 69
PREDNISONE 85 85 29 33
CYMBALTA 85 85 29 44
CARVEDILOL 84 84 31 24
CARBIDOPA-LEVODOPA 83 83 32 142
ESCITALOPRAM OXALATE 82 82 33 79
TRAMADOL HCL 79 79 34 16
ATORVASTATIN CALCIUM 77 77 35 11
EXELON 72 72 36 120
DILTIAZEM 24HR ER 67 66 37 143
ATENOLOL 66 66 38 28
ALENDRONATE SODIUM 64 61 39 40
FINASTERIDE 64 64 39 132
ZOLPIDEM TARTRATE 61 60 41 15
TRAZODONE HCL 61 60 41 38
NEXIUM 59 59 43 19
PAROXETINE HCL 58 58 44 73
OLANZAPINE 58 57 44 156
SPIRONOLACTONE 57 57 46 75
CLOPIDOGREL 55 55 47 31
SYNTHROID 54 54 48 61
CIPROFLOXACIN HCL 53 48 49 62
SEROQUEL 52 52 50 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.